JP2011521661A5 - - Google Patents

Download PDF

Info

Publication number
JP2011521661A5
JP2011521661A5 JP2011512126A JP2011512126A JP2011521661A5 JP 2011521661 A5 JP2011521661 A5 JP 2011521661A5 JP 2011512126 A JP2011512126 A JP 2011512126A JP 2011512126 A JP2011512126 A JP 2011512126A JP 2011521661 A5 JP2011521661 A5 JP 2011521661A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
xyloglucanase
variant
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2011512126A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011521661A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/056875 external-priority patent/WO2009147210A1/en
Publication of JP2011521661A publication Critical patent/JP2011521661A/ja
Publication of JP2011521661A5 publication Critical patent/JP2011521661A5/ja
Ceased legal-status Critical Current

Links

JP2011512126A 2008-06-06 2009-06-04 ファミリー44キシログルカナーゼのバリアント Ceased JP2011521661A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08157769.4 2008-06-06
EP08157769 2008-06-06
PCT/EP2009/056875 WO2009147210A1 (en) 2008-06-06 2009-06-04 Variants of a family 44 xyloglucanase

Publications (2)

Publication Number Publication Date
JP2011521661A JP2011521661A (ja) 2011-07-28
JP2011521661A5 true JP2011521661A5 (enExample) 2012-07-19

Family

ID=40933798

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011512126A Ceased JP2011521661A (ja) 2008-06-06 2009-06-04 ファミリー44キシログルカナーゼのバリアント

Country Status (9)

Country Link
US (3) US8709777B2 (enExample)
EP (3) EP2905333B1 (enExample)
JP (1) JP2011521661A (enExample)
CN (2) CN104017789B (enExample)
AU (1) AU2009254546B2 (enExample)
CA (1) CA2727005A1 (enExample)
MX (1) MX2010013183A (enExample)
RU (1) RU2545721C2 (enExample)
WO (1) WO2009147210A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103232984B (zh) * 2013-04-10 2014-08-27 中国科学院南海海洋研究所 一种新颖的糖苷水解酶家族44的纤维素酶及其编码基因和应用
CN104388406B (zh) * 2014-10-29 2017-02-15 广西大学 一种内切木葡聚糖酶及其应用
CA3000298A1 (en) * 2015-10-23 2017-04-27 Novozymes A/S Use of cellulase to improve viscosity control of dissolving pulp
MX2023001888A (es) 2020-08-25 2023-03-10 Novozymes As Variantes de una xiloglucanasa de la familia 44.
US20250179393A1 (en) 2022-03-02 2025-06-05 Novozymes A/S Use of xyloglucanase for improvement of sustainability of detergents
WO2023247348A1 (en) 2022-06-21 2023-12-28 Novozymes A/S Mannanase variants and polynucleotides encoding same
EP4461796A1 (en) 2023-05-10 2024-11-13 Novozymes A/S Detergent composition comprising laccase
EP4461795A1 (en) 2023-05-10 2024-11-13 Novozymes A/S Detergent composition comprising laccase
CN120966803A (zh) * 2025-10-20 2025-11-18 安琪酵母股份有限公司 谷氨酰胺酶突变体及其应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK122686D0 (da) 1986-03-17 1986-03-17 Novo Industri As Fremstilling af proteiner
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
DK16490D0 (da) * 1990-01-19 1990-01-19 Novo Nordisk As Enzym
IL99552A0 (en) 1990-09-28 1992-08-18 Ixsys Inc Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof
ES2202320T3 (es) 1992-12-23 2004-04-01 Novozymes A/S Enzima con actividad de endoglucanasa.
DE4343591A1 (de) 1993-12-21 1995-06-22 Evotec Biosystems Gmbh Verfahren zum evolutiven Design und Synthese funktionaler Polymere auf der Basis von Formenelementen und Formencodes
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
WO1996000787A1 (en) 1994-06-30 1996-01-11 Novo Nordisk Biotech, Inc. Non-toxic, non-toxigenic, non-pathogenic fusarium expression system and promoters and terminators for use therein
WO1996034946A1 (en) 1995-05-05 1996-11-07 Novo Nordisk A/S Protease variants and compositions
EP0937138B1 (en) * 1996-09-17 2006-04-26 Novozymes A/S Cellulase variants
JP3961767B2 (ja) 1997-07-07 2007-08-22 ノボザイムス アクティーゼルスカブ アルカリ性キシログルカナーゼ
AU8327898A (en) * 1997-07-11 1999-02-08 Her Majesty The Queen In Right Of Canada As Represented By The Department Of Agriculture And Agri-Food Canada Strains of (coniothyrium minitans) having 1,3 and 1,4 beta-glucanase activity
EP0905306A1 (de) * 1997-09-26 1999-03-31 Consortium für elektrochemische Industrie GmbH Mehrkomponentensystem zum Verändern, Abbau oder Bleichen von Lignin, ligninhaltigen Materialien sowie Verfahren zu seiner Anwendung
US5955310A (en) 1998-02-26 1999-09-21 Novo Nordisk Biotech, Inc. Methods for producing a polypeptide in a bacillus cell
DE60137678D1 (de) 2000-02-24 2009-04-02 Novozymes As Xyloglukanase gehörend zur familie 44 der glykosilhydrolase
US6815192B2 (en) * 2000-02-24 2004-11-09 Novozymes A/S Family 44 xyloglucanases
DE60040591D1 (de) * 2000-03-20 2008-12-04 Audemars Piguet Renaud Et Papi Ratschenantriebsmechanismus für Aufzugssperrad in einer Uhr
DE60222914T2 (de) 2001-07-27 2008-07-24 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Systeme zur stellengerichteten in-vivo-mutagenese mit oligonukleotiden
AU2003223928A1 (en) 2002-05-07 2003-11-11 Novozymes A/S Homologous recombination into bacterium for the generation of polynucleotide libraries
US20080015135A1 (en) 2006-05-05 2008-01-17 De Buzzaccarini Francesco Compact fluid laundry detergent composition
WO2007149806A1 (en) 2006-06-19 2007-12-27 The Procter & Gamble Company Liquid detergent compositions with low polydispersity polyacrylic acid based polymers
CN102057030B (zh) 2008-06-06 2016-05-11 宝洁公司 包含家族44木葡聚糖酶变体的洗涤剂组合物

Similar Documents

Publication Publication Date Title
JP2011521661A5 (enExample)
JP2009268467A5 (enExample)
JP2013530689A5 (enExample)
HRP20192314T1 (hr) Pripravci faktora viii i postupci pripreme i njihove uporabe
CL2019002280A1 (es) Vectores virales, adenovirales y composiciones a base de una secuencia de ornitina transcarbamilasa humana (hotch) modificada genéticamente y su uso en el tratamiento de deficiencia de la otc. (divisional solicitud 201602235)
JP2012531889A5 (enExample)
JP2013027391A5 (enExample)
JP2014501510A5 (enExample)
FI3313991T3 (fi) Muunnettu tekijä IX sekä koostumukset, menetelmät ja käytöt geeninsiirtoa varten soluihin, elimiin ja kudoksiin
JP2019536462A5 (enExample)
JP2006149395A5 (enExample)
JP2014000092A5 (enExample)
JP2010166916A5 (enExample)
JP2008538183A5 (enExample)
JP2014012022A5 (enExample)
JP2018532428A5 (enExample)
JP2016034981A5 (enExample)
JP2013523179A5 (enExample)
JP2012065678A5 (enExample)
JP2012518420A5 (enExample)
JP2009528843A5 (enExample)
JP2018520997A5 (enExample)
JP2015521465A5 (enExample)
WO2013151672A3 (en) Modified polynucleotides for the production of oncology-related proteins and peptides
MX2020005458A (es) Variantes de alfa-amilasa y polinucleotidos que codifican las mismas.